myocardial infarction

39 all articles · 20 / page

Ask MedXY AI

Latest news

Tag

All articles

Low-Dose Colchicine Reduces Myocardial Infarction and Stroke Risk in Cardiovascular Disease Patients

A large meta-analysis shows colchicine can lower MI and stroke risk without raising serious adverse events, but GI side effects remain a concern.

Section: CardiologyDec 16, 2025

Intracoronary Wharton’s Jelly Mesenchymal Stem Cells After STEMI Reduce Incident Heart Failure: Phase 3 PREVENT-TAHA8 Results

A phase 3 randomized trial found intracoronary infusion of allogeneic Wharton’s jelly mesenchymal stem cells (WJ-MSCs) after STEMI reduced new-onset heart failure and HF readmissions and improved LVEF versus standard care over a median 33-m

myocardial infarction

Latest news

Low-Dose Colchicine Reduces Myocardial Infarction and Stroke Risk in Cardiovascular Disease Patients

Intracoronary Wharton’s Jelly Mesenchymal Stem Cells After STEMI Reduce Incident Heart Failure: Phase 3 PREVENT-TAHA8 Results

Myocardial Infarction and Late-Onset Epilepsy: Unraveling Bidirectional Vascular Risks in Aging Populations

LOX‑1 Blockade After MI Reduced sLOX‑1 and IL‑6 but Not Coronary Noncalcified Plaque: Lessons from GOLDILOX‑TIMI 69

No Routine Benefit from Beta‑Blockers After Myocardial Infarction with Preserved Ejection Fraction: Individual‑Patient Meta‑analysis of Five Randomized Trials

Dietary Patterns and Intracranial Atherosclerosis Risk in Elderly Patients With Hypertension or Myocardial Infarction: An Evidence-Based Review

β-Blockers in Post-Myocardial Infarction Patients with Mildly Reduced Ejection Fraction: A Meta-Analysis of Randomized Trials

Sustained Benefits of Physiology-Guided Complete Revascularization in Elderly Myocardial Infarction Patients: Insights from the FIRE Trial Three-Year Follow-Up

Multidomain Rehabilitation Reduces Cardiovascular Events in Older Adults Post-Myocardial Infarction: Insights from the PIpELINe Trial

Reevaluating Beta-Blocker Therapy Post-Myocardial Infarction with Preserved Ejection Fraction: Insights from Recent Trials and Meta-Analyses

Safety of Beta Blocker Withdrawal After Myocardial Infarction Without Reduced Ejection Fraction: Insights from the REBOOT Trial Post Hoc Analysis

Sex-Specific Outcomes of Beta-Blocker Therapy After Myocardial Infarction: Insights from the REBOOT Trial

Routine Helicobacter pylori Screening Post-Myocardial Infarction: Insights from the HELP-MI SWEDEHEART Trial

Routine Helicobacter pylori Screening Post-Myocardial Infarction: Insights from the HELP-MI SWEDEHEART Trial

Tongxinluo in Cardiovascular Disease: Mechanisms, Clinical Efficacy, and Future Directions

Optimizing Blood Transfusion Strategies in Acute Myocardial Infarction with Anemia and Heart Failure: Insights from the MINT Trial

Enhancing Cardiovascular Risk Prediction and Outcomes with Coronary CT Angiography: Insights from the PROMISE and SCOT-HEART Trials

Beta-blocker Interruption Effects on Blood Pressure and Heart Rate After Myocardial Infarction: The AβYSS Trial

Widespread Misclassification of Myocardial Infarction Subtypes in Administrative Coding: Implications for Practice and Policy